These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2507950)

  • 1. Effect of hemodialysis on serum concentrations of HPLC-analyzed accumulating solutes in uremia.
    Schoots AC; Peeters JA; Gerlag PG
    Nephron; 1989; 53(3):208-17. PubMed ID: 2507950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of endogenous ligand solutes that bind to serum proteins in sera of patients with uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1986; 43(2):110-6. PubMed ID: 3086761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
    Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
    Lesaffer G; De Smet R; Lameire N; Dhondt A; Duym P; Vanholder R
    Nephrol Dial Transplant; 2000 Jan; 15(1):50-7. PubMed ID: 10607767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of urea and other uremic markers for quantification of dialysis efficacy.
    Vanholder RC; De Smet RV; Ringoir SM
    Clin Chem; 1992 Aug; 38(8 Pt 1):1429-36. PubMed ID: 1643710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the classical markers sufficient to describe uremic solute accumulation in dialyzed patients? Hippurates reconsidered.
    Schoots AC; Dijkstra JB; Ringoir SM; Vanholder R; Cramers CA
    Clin Chem; 1988 Jun; 34(6):1022-9. PubMed ID: 3378319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
    Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
    Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on protein-bound uremic retention solutes.
    Vanholder R; Schepers E; Pletinck A; Neirynck N; Glorieux G
    J Ren Nutr; 2012 Jan; 22(1):90-4. PubMed ID: 22200422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-bound uremic retention solutes.
    Brunet P; Dou L; Cerini C; Berland Y
    Adv Ren Replace Ther; 2003 Oct; 10(4):310-20. PubMed ID: 14681860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The removal of protein-bound solutes by dialysis.
    Meyer TW
    J Ren Nutr; 2012 Jan; 22(1):203-6. PubMed ID: 22200443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
    ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid-chromatographic profiling of solutes in serum of uremic patients undergoing hemodialysis and chronic ambulatory peritoneal dialysis (CAPD); high concentrations of pseudouridine in CAPD patients.
    Schoots AC; Gerlag PG; Mulder AW; Peeters JA; Cramers CA
    Clin Chem; 1988 Jan; 34(1):91-7. PubMed ID: 3338190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.
    Leong SC; Sao JN; Taussig A; Plummer NS; Meyer TW; Sirich TL
    J Am Soc Nephrol; 2018 Jul; 29(7):1992-1999. PubMed ID: 29728422
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis.
    Niwa T; Asada H; Tsutsui S; Miyazaki T
    Am J Nephrol; 1995; 15(6):463-7. PubMed ID: 8546166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.
    Jhawar S; Singh P; Torres D; Ramirez-Valle F; Kassem H; Banerjee T; Dolgalev I; Heguy A; Zavadil J; Lowenstein J
    PLoS One; 2015; 10(3):e0118703. PubMed ID: 25811877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
    Sirich TL; Fong K; Larive B; Beck GJ; Chertow GM; Levin NW; Kliger AS; Plummer NS; Meyer TW;
    Kidney Int; 2017 May; 91(5):1186-1192. PubMed ID: 28089366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.